Differences between US and European patent applications
The differences in the ways US patent and European patent (EP) applications are drafted often pose problems during substantive examination when an EP application is filed based on a US application.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
5 January 2022 A duo of cases from the Federal Circuit has added complexities to the drafting of patent applications for antibody inventions, explain Hailey Bureau of BSKB and Olayinka Oladele of the Thurgood Marshall School of Law.